Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer

被引：0
|
作者：
Ardavanis, A
Scorilas, A
Amanatidou, A
Gerakini, F
Missitzis, I
Garoufali, A
Pissakas, G
Pateras, C
Apostolikas, N
Rigatos, G
Yiotis, I
机构：
[1] ST SAVVAS CANC HOSP,HORMONAL RECEPTORS LAB,ATHENS 11522,GREECE
[2] ST SAVVAS CANC HOSP,BREAST CLIN,ATHENS 11522,GREECE
[3] ST SAVVAS CANC HOSP,RADIOTHERAPY DEPT 2,ATHENS 11522,GREECE
[4] ST SAVVAS CANC HOSP,PATHOL LAB,ATHENS 11522,GREECE
来源：
ANTICANCER RESEARCH | 1997年 / 17卷 / 2B期
关键词：
breast cancer; prognostic factors; cathepsin D;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
One hundred and seventy three women were followed-up for a median of 62 months after surgery for Stage I-III breast cancer: The concentration of cathepsin D (CD) in tumor cytosols was compared to the standard prognostic factors for the disease and related to relapse free and overall survival and type of relapse. Three groups were identified with different prognostic profile. High CD levels significantly shorten DFS ill both node-negative and node-positive patients; a correlation between high cathepsin D levels and locoregional relapse should also be noted. This marker should be included in the initial evaluation of breast cancer as an indicator of invasiveness.
引用
收藏
页码：1405 / 1409
页数：5
相关论文
共 50 条
  • [11] Prognostic value of cathepsin D in breast cancer
    Westley, BR
    May, FEB
    BRITISH JOURNAL OF CANCER, 1999, 79 (02) : 189 - 190
  • [12] CORRELATION OF CATHEPSIN D IN PRIMARY BREAST-CANCER TO VARIOUS PROGNOSTIC FACTORS
    REMPEN, A
    CAFFIER, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1991, 51 (04) : 272 - 275
  • [13] PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D IN PRIMARY BREAST-CANCER
    CROMBACH, G
    INGENHORST, A
    GOHRING, UJ
    SCHARL, A
    SCHAEFFER, HJ
    STUTZER, H
    BOLTE, A
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1994, 54 (10) : 545 - 551
  • [14] EVALUATION OF CATHEPSIN-D AS A PROGNOSTIC FACTOR IN BREAST-CANCER - RESPONSE
    ROCHEFORT, H
    THORPE, S
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (01) : 107 - 109
  • [15] EVALUATION OF CATHEPSIN-D AS A PROGNOSTIC FACTOR IN BREAST-CANCER - REPLY
    RAVDIN, PM
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (01) : 110 - 111
  • [16] Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer
    Scorilas, A
    Talieri, M
    Ardavanis, A
    Courtis, N
    Dimitriadis, E
    Yotis, J
    Tsiapalis, CM
    Trangas, T
    CANCER RESEARCH, 2000, 60 (19) : 5427 - 5433
  • [17] Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor
    Zucali, R
    Mariani, L
    Marubini, E
    Kenda, R
    Lozza, L
    Rilke, F
    Veronesi, U
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1363 - 1366
  • [18] Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients
    Liebert, A
    Quietzsch, D
    Beier, L
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2571 - 2576
  • [19] Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: Inconsistency with their established prognostic significance
    Ardavanis, A
    Gerakini, F
    Amanatidou, A
    Scorilas, A
    Pateras, C
    Garoufali, A
    Pissakas, G
    Stravolemos, K
    Apostolikas, N
    Yiotis, I
    ANTICANCER RESEARCH, 1997, 17 (5A) : 3665 - 3669
  • [20] Prognostic value of cathepsin D in breast cancer (BC) patients
    Adrover, E
    Maestro, ML
    Sanz-Casla, T
    Del Barco, V
    Valor, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S92 - S92
12345